TC
BMGL

T3 Companies’s Basel Medical BMGL Stock Holding History

T3 Companies’s Portfolio BMGL Stock Details BMGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.85K Buy
+1,250
New +$9.89K 0.01% 120

Other funds holding BMGL

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T3 Companies's BMGL Position: Q1 2026 in Review

T3 Companies opened a new position in Basel Medical (BMGL) in Q1 2026: 1,250 shares worth $8.85K. The stake represents 0.01% of the portfolio and ranks #120 among its holdings.

4 funds tracked by Wall St. Rank hold BMGL as of Q1 2026.

  • T3 Companies held 1,250 shares of Basel Medical worth $8.85K as of Q1 2026.
  • Basel Medical was a new T3 Companies position in Q1 2026.
  • Basel Medical made up 0.01% of T3 Companies's portfolio in Q1 2026, its #120 holding.
  • 4 funds tracked by Wall St. Rank held Basel Medical as of Q1 2026.

Based on T3 Companies's 13F filing for Q1 2026, filed 7 May 2026.